Cumberland Pharmaceuticals Inc. (CPIX) financial statements and ratios from SEC XBRL: revenue $44.52M (TTM), net margin -6.4%, revenue growth -22.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $44.52M |
| Net Margin | -6.4% |
| Revenue Growth (YoY) | -22.0% |
| EPS Growth (YoY) | -375.0% |
| FCF Growth (YoY) | -89.9% |
| Price / Book | 6.67 |
| Price / Sales | 4.01 |
| FCF Yield | 9.1% |
| DCF Value (model) | $6.88 |
| DCF Upside vs Price | -9.7% |
| Altman Z-Score | 1.28 (distress) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.7 |
CPIX overview · CPIX earnings · CPIX KPIs · CPIX investor relations · CPIX ownership · CPIX peers · CPIX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.